Synergistic Antitumor Effects of Regulatory T Cell Blockade Combined with Pemetrexed in Murine Malignant Mesothelioma
Open Access
- 15 July 2010
- journal article
- Published by The American Association of Immunologists
- Vol. 185 (2), 956-966
- https://doi.org/10.4049/jimmunol.0900437
Abstract
CD4+CD25+ regulatory T cells (Tregs) can promote the growth of some tumors, but it is unknown whether this is true for all tumors, including malignant pleural mesothelioma. We have previously shown that the existence of Tregs was associated with poor survival in patients with malignant pleural mesothelioma. In this study, using an intrathoracic murine model of malignant mesothelioma (MM), we provide evidence suggesting that Treg blockade could enhance survival when combined with pemetrexed in established tumor. AC29 murine MM cells were injected into the right pleural cavity of CBA mice for tumor development. Four days after the tumor injection, tumor-bearing mice were then treated with pemetrexed alone, Treg blockade alone, or a combination of pemetrexed and Treg blockade. We observed a synergistic antitumor effect of Treg blockade combined with pemetrexed resulting in prolonged survival. The combination of Treg blockade and pemetrexed was associated with decreased tumor-infiltrating Tregs, increased IL-2 production, dendritic cell maturation, and increased CD3+CD8+IFN-γ+ tumor-infiltrating T cells when compared with mice treated with pemetrexed alone or Treg blockade alone. The survival benefit was abrogated if anti-CD8 mAb was administered simultaneously. Likewise, the survival benefit resulting from the combined Treg blockade with pemetrexed was not observed when immunodeficient mice were used. Therefore, this study suggests that Treg blockade combined with pemetrexed can suppress mesothelioma growth in established tumor in vivo through an immune-mediated process. This study also validates a new intrathoracic tumor model of pleural effusion to explore the role of antitumor immunity in murine MM.Keywords
This publication has 31 references indexed in Scilit:
- Consolidative Dendritic Cell-based Immunotherapy Elicits Cytotoxicity against Malignant MesotheliomaAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Cyclophosphamide Chemotherapy Sensitizes Tumor Cells to TRAIL-Dependent CD8 T Cell-Mediated Immune Attack Resulting in Suppression of Tumor GrowthPLOS ONE, 2009
- Transforming Growth Factor-β Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid CancersClinical Cancer Research, 2008
- The anticancer immune response: indispensable for therapeutic success?JCI Insight, 2008
- Adoptive cell transfer: a clinical path to effective cancer immunotherapyNature Reviews Cancer, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Inhibition of TGF-β with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progressionJCI Insight, 2007
- CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curativeEuropean Journal of Immunology, 2004
- Lineage relationship and protective immunity of memory CD8 T cell subsetsNature Immunology, 2003
- Establishment of a murine model of malignant mesotheliomaInternational Journal of Cancer, 1992